Print Page     Close Window     

SEC Filings

10-K
SERES THERAPEUTICS, INC. filed this Form 10-K on 03/06/2019
Entire Document
 

TABLE OF CONTENTS

 

 

 

 

Page

PART I.

 

Item 1.

 

Business

5

Item 1A.

 

Risk Factors

33

Item 1B.

 

Unresolved Staff Comments

66

Item 2.

 

Properties

66

Item 3.

 

Legal Proceedings

66

Item 4.

 

Mine Safety Disclosures

66

 

 

 

PART II.

 

 

 

Item 5.

 

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

70

Item 6.

 

Selected Financial Data

71

Item 7.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

72

Item 7A.

 

Quantitative and Qualitative Disclosures about Market Risk

88

Item 8.

 

Financial Statements and Supplementary Data

88

Item 9.

 

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

88

Item 9A.

 

Controls and Procedures

89

Item 9B.

 

Other Information

89

 

 

 

PART III.

 

 

 

Item 10.

 

Directors, Executive Officers and Corporate Governance

90

Item 11.

 

Executive Compensation

90

Item 12.

 

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

90

Item 13.

 

Certain Relationships and Related Transactions and Director Independence

90

Item 14.

 

Principal Accountant Fees and Services

90

 

 

 

PART IV.

 

 

 

Item 15.

 

Exhibits and Financial Statement Schedules

91

Item 16.

 

Form 10-K Summary

92

 

 

 

SIGNATURES

 

 

 

2



© Seres Therapeutics. All Rights Reserved.